**Core Concept:** Glucokinase is an enzyme that plays a crucial role in the regulation of glucose levels in the body, specifically in the liver. It is involved in the conversion of glucose to glycogen for storage and helps maintain glucose homeostasis. The inhibition of glucokinase could lead to hyperglycemia, as the liver would not efficiently store glucose.

**Why the Correct Answer is Right:** Glucokinase is inhibited by the drug chlorpropamide (Diabinese). Chlorpropamide is an oral anti-diabetic drug that works by competitively inhibiting glucokinase, reducing glucose uptake by liver cells and inhibiting glycogen synthesis. This results in decreased glucose production and elevated glucose uptake from the bloodstream, leading to improved glucose control in diabetic patients.

**Why Each Wrong Option is Incorrect:**

A. Insulin is a hormone that lowers blood glucose levels, not raises them. Inhibition of insulin would not cause hyperglycemia, as it would lead to increased glucose uptake by target tissues and decreased glucose production by the liver.

B. Glucagon is another hormone that raises blood glucose levels, again not causing hyperglycemia. Glucagon stimulates gluconeogenesis and glycogenolysis in the liver, leading to increased glucose production and elevated blood glucose levels.

C. Glucagon-like peptide-1 (GLP-1) is a hormone that lowers blood glucose levels, counteracting the action of glucagon and not causing hyperglycemia. GLP-1 promotes insulin release from the pancreas and inhibits glucagon release, which contributes to glucose homeostasis.

D. Thiazolidinediones (e.g., pioglitazone) are a class of drugs used to treat type 2 diabetes by increasing insulin sensitivity. They do not cause hyperglycemia, as their primary action is to improve glucose uptake by muscle, adipose tissue, and liver cells, decreasing blood glucose levels.

**Clinical Pearl:** Understanding the pharmacology of anti-diabetic drugs is crucial for proper medication management in patients with diabetes. Inhibiting glucokinase, like chlorpropamide, is one approach to control hyperglycemia, while stimulating insulin and glucagon, inhibiting GLP-1, or promoting insulin sensitivity with thiazolidinediones are alternative strategies to manage hyperglycemia.

It is essential to have a good grasp of these pharmacological actions to prescribe medications appropriately and monitor their effects in patients with diabetes.